There continues to be significant interest from both clinicians and patients in using faecal transplantation, as the integral role of the gut microbiome is increasingly recognised in various disease conditions, both within and beyond the gut. This Clinical Perspectives article provides an overview of existing literature, factors limiting the use of faecal microbial transplantation in clinical practice and exciting new advancements on the horizon.
Keywords: faecal microbiota transplantation; gastrointestinal microbiome; immune checkpoint inhibitors; inflammatory bowel diseases; ulcerative colitis.
© 2024 Royal Australasian College of Physicians.